175 related articles for article (PubMed ID: 2546703)
1. HLA class II mRNA accumulation by activated human T cells following growth in conditioned medium.
Gansbacher B; Zier KS
Clin Exp Immunol; 1989 Jun; 76(3):440-5. PubMed ID: 2546703
[TBL] [Abstract][Full Text] [Related]
2. Differential surface expression of class II isotypes on activated CD4 and CD8 cells correlates with levels of locus-specific mRNA.
Diedrichs M; Schendel DJ
J Immunol; 1989 May; 142(9):3275-80. PubMed ID: 2785139
[TBL] [Abstract][Full Text] [Related]
3. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
[TBL] [Abstract][Full Text] [Related]
4. Regulation of HLA-DR, DP, and DQ expression in activated T cells.
Gansbacher B; Zier KS
Cell Immunol; 1988 Nov; 117(1):22-34. PubMed ID: 3263216
[TBL] [Abstract][Full Text] [Related]
5. Expression and function of class II antigens on gastric carcinoma cells and gastric epithelia: differential expression of DR, DQ, and DP antigens.
Sakai K; Takiguchi M; Mori S; Kobori O; Morioka Y; Inoko H; Sekiguchi M; Kano K
J Natl Cancer Inst; 1987 Nov; 79(5):923-32. PubMed ID: 2960847
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
[TBL] [Abstract][Full Text] [Related]
7. Induction of MHC class II molecules HLA-DR, -DP and -DQ and ICAM 1 in human podocytes by gamma-interferon.
Baudeau C; Delarue F; Hé CJ; Nguyen G; Adida C; Peraldi MN; Sraer JD; Rondeau E
Exp Nephrol; 1994; 2(5):306-12. PubMed ID: 7812737
[TBL] [Abstract][Full Text] [Related]
8. [Differential expression of HLA DR, DP and DQ in cultivated, human ciliary body epithelial cells].
Helbig H; Kittredge KL; Coca-Prados M; Nussenblatt RB
Fortschr Ophthalmol; 1991; 88(3):295-8. PubMed ID: 1889783
[TBL] [Abstract][Full Text] [Related]
9. Evidence for a specific post-transcriptional mechanism controlling the expression of HLA-DQ, but not -DR and -DP, molecules.
De Lerma Barbaro A; Sartoris S; Tosi G; Nicolis M; Accolla RS
J Immunol; 1994 Nov; 153(10):4530-8. PubMed ID: 7525708
[TBL] [Abstract][Full Text] [Related]
10. Molecular studies of a rare DR2/LD-5a/DQw3 HLA class II haplotype. Multiple genetic mechanisms in the generation of polymorphic HLA class II genes.
Liu CP; Bach FH; Wu SK
J Immunol; 1988 May; 140(10):3631-9. PubMed ID: 3129499
[TBL] [Abstract][Full Text] [Related]
11. Differential susceptibility to recombinant interferon-gamma-induced HLA-DQ antigen modulation among clones from a human metastatic melanoma.
Anichini A; Castelli C; Sozzi G; Fossati G; Parmiani G
J Immunol; 1988 Jan; 140(1):183-91. PubMed ID: 3121738
[TBL] [Abstract][Full Text] [Related]
12. An isotype-specific trans-acting factor is defective in a mutant B cell line that expresses HLA-DQ, but not -DR or -DP.
Ono SJ; Bazil V; Sugawara M; Strominger JL
J Exp Med; 1991 Mar; 173(3):629-37. PubMed ID: 1997650
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of HLA-class II antigen mRNAs on T lymphoblasts].
Tate G; Katagiri M
Hokkaido Igaku Zasshi; 1986 Mar; 61(2):249-56. PubMed ID: 3487495
[TBL] [Abstract][Full Text] [Related]
14. Evidence for a lymphocyte activation determinant coded by the HLA region different from HLA-DR, DQ, and DP.
Eiermann TH; Martin A; Wölpl A; Goldmann SF
Transplant Proc; 1987 Feb; 19(1 Pt 1):866-9. PubMed ID: 3824496
[No Abstract] [Full Text] [Related]
15. Immunohistochemical analysis of HLA class II antigens and tumor infiltrating mononuclear cells in renal cell carcinoma: correlation with clinical and histopathological data.
Brasanac D; Marković-Lipkovski J; Hadzi-Djokić J; Müller GA; Müller CA
Neoplasma; 1999; 46(3):173-8. PubMed ID: 10613593
[TBL] [Abstract][Full Text] [Related]
16. HLA class II molecules (HLA-DR, -DP, -DQ) on cells in the human CNS studied in situ and in vitro.
Ulvestad E; Williams K; Bø L; Trapp B; Antel J; Mørk S
Immunology; 1994 Aug; 82(4):535-41. PubMed ID: 7835916
[TBL] [Abstract][Full Text] [Related]
17. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes.
Tsujisaki M; Igarashi M; Sakaguchi K; Eisinger M; Herlyn M; Ferrone S
J Immunol; 1987 Feb; 138(4):1310-6. PubMed ID: 3100635
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
Howard DR; Eaves AC; Takei F
Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
[TBL] [Abstract][Full Text] [Related]
19. HLA-DR and DQ antigens in chronic lymphocytic leukemia: dissociation of expression revealed by cell surface, protein, and mRNA studies.
Kraïba R; Loiseau P; Faille A; Poirier O; Piatier-Tonneau D; Degos L; Abita JP; Charron D
Leukemia; 1989 May; 3(5):386-93. PubMed ID: 2497283
[TBL] [Abstract][Full Text] [Related]
20. Activated T cells and monocytes have characteristic patterns of class II antigen expression.
Robbins PA; Maino VC; Warner NL; Brodsky FM
J Immunol; 1988 Aug; 141(4):1281-7. PubMed ID: 3135327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
